We are live on ! Find out more
OAC

OMERS Administration Corp Portfolio holdings

AUM $16.7B
1-Year Est. Return 35.96%
This Fund
S&P 500
This Quarter Est. Return
+23.08%
1 Year Est. Return
+35.96%
3 Year Est. Return
+106.41%
5 Year Est. Return
+114.67%
10 Year Est. Return
+344.51%
AUM
$16.7B
AUM Growth
+$1.16B
Cap. Flow
-$545M
Cap. Flow %
-3.26%
Top 10 Hldgs %
30.99%
Holding
1,188
New
92
Increased
466
Reduced
166
Closed
282

Top Sells

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$463M
2
AAPL icon
Apple
AAPL
+$266M
3
PLD icon
Prologis
PLD
+$192M
4
NVDA icon
NVIDIA
NVDA
+$168M
5
KO icon
Coca-Cola
KO
+$164M

Sector Composition

Rank Sector Weight
1 Technology 25.31%
2 Financials 22.79%
3 Industrials 9.5%
4 Communication Services 8.24%
5 Consumer Discretionary 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XFOR icon
1151
X4 Pharmaceuticals
XFOR
$337M
-57,300
Closed -$237K
Z icon
1152
Zillow
Z
$7.38B
-8,249
Closed -$341K
GTM
1153
ZoomInfo Technologies
GTM
$1.14B
-12,600
Closed -$75.3K
ZNTL icon
1154
Zentalis Pharmaceuticals
ZNTL
$385M
-47,700
Closed -$112K
ZURA icon
1155
Zura Bio
ZURA
$590M
-29,800
Closed -$177K
ANRO icon
1156
Alto Neuroscience
ANRO
$1.42B
-9,700
Closed -$218K
GUTS icon
1157
Fractyl Health
GUTS
$110M
-123,900
Closed -$56.7K
KYTX icon
1158
Kyverna Therapeutics
KYTX
$502M
-14,800
Closed -$128K
AIFC
1159
AI Financial Corp
AIFC
$73.8M
-73,500
Closed -$81.6K
SOLV icon
1160
Solventum
SOLV
$15.3B
-6,704
Closed -$438K
CTNM
1161
Contineum Therapeutics
CTNM
$612M
-14,200
Closed -$185K
ULS icon
1162
UL Solutions
ULS
$14.8B
-4,300
Closed -$369K
ARTV
1163
Artiva Biotherapeutics
ARTV
$535M
-11,400
Closed -$73.4K
BKV
1164
BKV Corp
BKV
$2.93B
-7,700
Closed -$220K
CLYM
1165
Climb Bio
CLYM
$908M
-16,700
Closed -$114K
IRD
1166
Opus Genetics
IRD
$367M
-41,600
Closed -$189K
VENU
1167
Venu Holding Corp
VENU
$111M
-15,400
Closed -$51K
NUAI
1168
New Era Energy & Digital Inc
NUAI
$694M
-18,800
Closed -$76.3K
TTAN
1169
ServiceTitan Inc
TTAN
$8.01B
-3,200
Closed -$203K
DVLT
1170
Datavault AI
DVLT
$187M
-123,900
Closed -$76.6K
SNDK
1171
Sandisk
SNDK
$262B
-4,098
Closed -$2.6M
WHWK
1172
Whitehawk Therapeutics
WHWK
$257M
-11,500
Closed -$39.7K
SMA
1173
SmartStop Self Storage REIT
SMA
$1.81B
-30,000
Closed -$908K
CGCTU
1174
DELISTED
Cartesian Growth Corp III Unit
CGCTU
-12,060
Closed -$128K
MNTN
1175
MNTN Inc
MNTN
$972M
-20,000
Closed -$176K

Similar funds

OMERS Administration Corp's Q2 2026 Portfolio in Review

As of Q2 2026, OMERS Administration Corp held 1,188 positions worth $16.7B, up 7.5% from $15.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

OMERS Administration Corp withdrew a net $545M in Q2 2026, closing 282 positions and reducing 166 holdings. Its most notable exit was AstraZeneca, an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

Against the trend, OMERS Administration Corp opened a new position in Brookfield Asset Management worth $30.3M.

  • OMERS Administration Corp's largest Q2 2026 buy was Brookfield Asset Management: 675,600 shares worth $30.3M.
  • OMERS Administration Corp added most to Canadian Natural Resources in Q2 2026, an estimated $318M increase.
  • OMERS Administration Corp's biggest Q2 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $463M.
  • OMERS Administration Corp fully exited AstraZeneca in Q2 2026, selling an estimated $160M.
  • OMERS Administration Corp's ten largest holdings make up 31% of its $16.7B portfolio in Q2 2026.
  • OMERS Administration Corp opened 92 new positions and closed 282 in Q2 2026.
  • OMERS Administration Corp's portfolio value rose 7.5% quarter-over-quarter to $16.7B.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.